BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Y, Wu C, Li W, Chen X, Li Z, Liao X, Cui Y, Zhao G, Liu M, Fu Z. 2-[18F]FDG PET/CT parameters associated with WHO/ISUP grade in clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging 2021;48:570-9. [PMID: 32814979 DOI: 10.1007/s00259-020-04996-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tan H, Ma M, Huang J, Zhu W, Hu S, Zheng K, Rong P. Glucose Metabolism Reprogramming of Primary Tumor and the Liver Is Associated With Disease-Free Survival in Patients With Early NSCLC. Front Oncol 2021;11:752036. [PMID: 34778067 DOI: 10.3389/fonc.2021.752036] [Reference Citation Analysis]
2 Hou G, Zhao D, Jiang Y, Zhu Z, Huo L, Li F, Cheng W. Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma. Cancer Imaging 2021;21:25. [PMID: 33632314 DOI: 10.1186/s40644-021-00393-8] [Reference Citation Analysis]
3 Roussel E, Capitanio U, Kutikov A, Oosterwijk E, Pedrosa I, Rowe SP, Gorin MA. Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review. Eur Urol 2022:S0302-2838(22)00083-5. [PMID: 35216855 DOI: 10.1016/j.eururo.2022.01.040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
4 Wu C, Cui Y, Liu J, Ma L, Xiong Y, Gong Y, Zhao Y, Zhang X, Chen S, He Q, Zhang J, Liu M, Fan Y. Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[18F]FDG PET/CT. Eur J Nucl Med Mol Imaging 2021. [PMID: 33978830 DOI: 10.1007/s00259-021-05399-9] [Reference Citation Analysis]
5 Salem AE, Fine GC, Covington MF, Koppula BR, Wiggins RH, Hoffman JM, Morton KA. PET-CT in Clinical Adult Oncology-IV. Gynecologic and Genitourinary Malignancies. Cancers (Basel) 2022;14:3000. [PMID: 35740665 DOI: 10.3390/cancers14123000] [Reference Citation Analysis]
6 Wu Q, Huang G, Wei W, Liu J. Molecular Imaging of Renal Cell Carcinoma in Precision Medicine. Mol Pharm 2022. [PMID: 35510710 DOI: 10.1021/acs.molpharmaceut.2c00034] [Reference Citation Analysis]